洞察市场格局
解锁药品研发情报

400客服电话

  • 购买数据产品

    400-9696-311 转1

  • 定制咨询业务

    400-9696-311 转2

  • 数据与AI定制业务

    400-9696-311 转3

  • 商务合作及其他问题

    400-9696-311 转4

  • 投诉及建议

    400-9696-311 转5

医药数据查询

首页 临床进展 Comparison of TIVA with a balanced anesthesia using propofol and low concentration sevoflurane: A BIS guided study

【ChiCTR1800016517】Comparison of TIVA with a balanced anesthesia using propofol and low concentration sevoflurane: A BIS guided study

查看原文
立即下载
基本信息
登记号

ChiCTR1800016517

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2018-06-06

临床申请受理号

/

靶点

/

适应症

Anesthetic effects on cardiovascular, neuromuscular and central nervous systems.

试验通俗题目

Comparison of TIVA with a balanced anesthesia using propofol and low concentration sevoflurane: A BIS guided study

试验专业题目

Comparison of total intravenous anesthesia versus a propofol target controlled infusion combined with low MAC sevoflurane

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

300007

联系人通讯地址
请登录查看
临床试验信息
试验目的

To compare total intravenous anesthesia (TIVA) to 2 groups of combined propofol and sevoflurane anesthesia under 1 MAC anesthesia to determine which technique could provide more favourable overall outcomes in terms of CVS stability, recovery time, consumption of intravenous anesthetics and postoperative side effects.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

诊断试验新技术

随机化

The consented subjects were selected in the outpatient department respecting our inclusion criteria by the chief residents of the respective surgical units. The patients were randomly scattered in a morning and afternoon session according to the surgical list with no specific order in age, sex and BMI.

盲法

The process of recruiting started two months before starting the pilot study. We ensured that a maximum of 2 experiments would be carried out per day, one in the morning and the other in the afternoon so that the conditions for proper recording of values would be more comfortable and accurate. Only name , type and order of surgery for each consented patient were collected in the outpatient department by a chief resident and handed over to the operating room charge nurse on a weekly basis. All personal data was hidden to the latter. The list was designed such that no repetition of the same type of surgery would recur daily. The chief-resident participated only in this step of the study. The person conducting the study and anesthesiologist was not in contact with any consented patient until their arrival to the operating room.

试验项目经费来源

天津医科大学总医院

试验范围

/

目标入组人数

40

实际入组人数

/

第一例入组时间

2016-10-17

试验终止时间

2017-07-19

是否属于一致性

/

入选标准

Aged 20-65 years, with American Society of Anesthesiologists (ASA) I-II physical status, BMI < 30 kg/m2 and due for elective abdominal, gynecological and lower limb surgeries under general anesthesia；

排除标准

Uncontrolled hypertension, diabetes, endocrinal disorders, neurological; Disorders including epilepsy, hepatic and renal impairment, neuromuscular disorders, BMI >30kg/m2, History of allergy, pregnant patients, patients on drugs which interfere with neuromuscular relaxants as anticonvulsants and aminoglycosides.；

研究者信息
研究负责人姓名
请登录查看
试验机构

天津医科大学总医院

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

300007

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

天津医科大学总医院的其他临床试验

更多

天津医科大学总医院的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品

天津医科大学总医院相关推荐

全球药物研发中心
全球研发数据与行业前沿情报

397,120个
全球在研药物数
1,108个
本月临床试验数
全球批准的新药
更多
全球首批
各国首批
数据来源：摩熵医药
更新时间：
研发动态
相关报告
政策法规
更多信息，请进入全球药物研发中心查看

医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测

2,883亿元
2026年Q3总销售额
6.14%(2026Q3)
TOP5企业市场份额
药品销售排行榜
查看完整数据
2025Q4医院化学药销售增速 *按市场份额排序
  • 1
    甲氨蝶呤注射液
  • 2
    克霉唑阴道乳膏
  • 3
    氯化钠注射液
核心能力
  • 医药市场销售数据分析 · 医院、实体药店、网上药店
  • 市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
更多信息，请进入医药市场洞察中心查看